NEW YORK (GenomeWeb News) – The Broad Institute of MIT and Harvard has bought 22 new Genome Analyzers, nearly doubling its stock of the Illumina-made sequencers, the company said today.

Broad conducts a wide range of biomedical genomics projects, and has worked in a partnership with the San Diego-based life sciences company. Before this purchase, Broad already had 25 of the analyzers in its tool shed, the company said.

In the coming year, Illumina said that it plans to increase the throughput of the analyzer to as much as 95 gigabases of DNA sequence data per run.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.